Introduction
============

Primary and metastatic hepatic malignancies are commonly treated by surgery, but radiation therapy is also one of options as non-surgical modalities. It has been demonstrated that radiation therapy is feasible and the outcomes are promising \[[@B1],[@B2]\]. However, due to respiration liver motion up to 3 cm \[[@B3]\] is one of obstacles to accurately localize the target. Moreover, respiratory-induced tumor motion is known to be anisotropic, thus individual determination of internal margin around gross tumor volume (GTV) is crucial to form an internal target volume (ITV), which can avoid both inadequate tumor coverage and unnecessary liver parenchymal irradiation for individual patient. Four-dimensional computed tomography (4D CT) is one of appropriate approaches to estimate and determine ITV for tumor with respiratory motion \[[@B4],[@B5]\].

4D CT has been widely used in lung cancer to determine ITV \[[@B6],[@B7]\]. Ideally, ITV should be delineated by manually contouring GTV in all 10 breath phases of a 4D scan image sets to form ITV, which is the most accurate tool to determine ITV, but it is a time-consuming and labor-intensive task. To reduce the workload of contouring multiple GTVs, one solution is to contour only two extreme phases at end-inhalation and end-exhalation and then to sum of the two becoming ITV \[[@B8],[@B9]\]; and the other is to use the post-processing tools of maximum intensity projection (MIP) and minimum intensity projection (MinIP) from 4D CT data sets to generate ITV. MIP-based ITV delineation is performed on a single 3-D CT data set, where each pixel in this set represents the brightest object encountered by corresponding voxels in all volumetric 4D CT data sets, for instance, MIP-based ITV delineation for lung cancer, which was recommended as a reliable tool and a good first estimation \[[@B10]-[@B12]\]. Conversely, MinIP-based ITV is on the CT set, where each pixel represents the lowest data value in the volumetric data \[[@B10]\].

MIP and MinIP methods seem not suitable for liver cancer because most tumors in the liver have similar attenuation to the normal liver parenchyma and therefore are not easily discernable. Contrast-enhanced CT scan has been routinely used for radiation oncologists to differentiate the tumor from normal tissues. It should be noted that regardless of with contrast enhancement or not, most liver tumors present inhomogeneous density, either because of the inherent nature of the tumor, such as the routes of blood supply, vascular volume and permeability, or because of areas of fluid, hemorrhage, and necrosis within tumors, or because of secondary change due to treatments, for example, iodine deposition as a result of transcatheter arterial chemoembolization (TACE). Recently, Beddar et al described a simple method for 4D CT acquisition by using synchronized intravenous contrast injection to improve the accuracy of liver tumor delineation. By this way most liver metastases and cholangiocarcinomas can be identified on image of portal venous phase, while HCC, most visible in the delayed phase \[[@B13]\].

In theory, for tumors with homogeneous hyperdensity or hypodensity comparing to the surrounding normal liver, MIP or MinIP projections should accordingly reflect the tumor trajectory across all time-resolved data sets. Visualization of tumor with mixed-density means the tumor border should be discernable; regardless which part of it is more hyperdense or hypodense than the adjacent liver parenchyma. Using MIP technique or MinIP technique only definitely misses the spatial information of the moving liver tumor. Therefore, our hypothesis is to combine MIP and MinIP, which may fit for the situation of mixed tumor density. Thus, the purpose of this study is to evaluate the feasibility and accuracy of the MIP and/or MinIP-based ITV delineation in 4DCT scans for liver tumors.

Methods
=======

Patient selection
-----------------

Patients who met the following criteria were qualified to this study: (1). Patient suffered from hepatic malignancies, primary or metastatic, and were planned to receive irradiation; (2). The margins of hepatic lesion were clear on intravenous contrast enhanced CT; (3). Patient\'s breath was regular after a training session; (4). Patient did not have the history of allege to contrast; and (5). Informed consent was obtained.

4D CT image acquisition
-----------------------

In order to enhance the visibility of tumors on 4D CT, 100 mL of contrast at a concentration of 300 mg I/mL was injected synchronously with 4D CT image acquisition. All patients were imaged during the portal venous phase. A time delay was programmed within 4D CT image acquisition protocol so that the start of contrast injection is initiated simultaneously with the start of the scanner\'s timer countdown. For those with liver metastases, the liver was scanned with a 45 s time delay, while for hepatocellular carcinoma (HCC) patients the time delay was 65 s. This CT scan protocol was proposed by Beddar et al \[[@B13]\].

All patients were immobilized using customized vacuum lock in supine position with arms placed on their forehead. A16-slice Brilliance Big Bore CT scanner (Philips Co.) was used for 4D CT image acquisition. The patient respiration was tracked using Real-Time Position Management (RPM) System (Varian Medical Systems, Palo Alto, CA). The region of interest usually comprises the area from 2 to 3 cm above diaphragm to iliac crest. A 4D CT scan is performed in cine mode with at least one complete breath cycle for each couch position. After scanning 4-dimensional images were binned based on the respiratory traces to become a complete image set, which covered each of 10 breathing phases. MIP and minimum intensity projections (MinIP) were then generated from the raw data set of 4D CT scans.

ITV determination
-----------------

All reconstructed CT series were transferred to MIM software (Version 5.1, MIMvista Corp., Cleveland, OH). Window/level was adjusted to optimize the visual contrast between the tumor and normal parenchyma regions. All the contours were drawn by a single radiation oncologist (JL) and verified by a senior radiation oncologist (JDZ). We used 5 approaches to determine ITV, which were: (1). ITV~AllPhases~: contouring GTV on each of 10 respiratory phases of 4D CT data set and combining these GTVs; (2). ITV~2Phase~: contouring GTV on CT of the peak inhale phase (0% phase) and the peak exhale phases (50%) and then combining the two; (3). ITV~MIP~: contouring GTV on MIP with modifications based on physician\'s visual verification of contours in each respiratory phase; (4). ITV~MinIP~: contouring GTV on MinIP with modification by physician; (5). ITV~2M~: combining ITV~MIP~and ITV~MinIP~. Figure [1](#F1){ref-type="fig"} illustrates different approaches in the determination of ITV for patient 13.

![**Panel (a) shows the GTV (green contour) for patient 13; Delineation of ITV base on ITV~AllPhases~, ITV~2Phase~, ITV~MIP~, ITV~MinIP~and ITV~2M~are shown in panels (b), (c), (d), (e) and (f), respectively**. ITV~MIP~and ITV~MinIP~coutours are as they appear on the intensity projection data set; all others are registered to the 0% phase of the 4D CT data set.](1748-717X-7-11-1){#F1}

Evaluation of target motion
---------------------------

We used MIM software (version 5.1) to measure cranio-caudal, left-right and anterior-posterior movement of the tumor. Tumor motion was also expressed as a 3D vector, which is the quadratic mean of the motions in 3 orthogonal directions.

Data analysis and statistics
----------------------------

ITV~2Phase~, ITV~MIP~, ITV~MinIP~and ITV~2M~, as the tested ITVs, would be compared with the reference of ITV~AllPhases~, respectively. The metrics used for comparison were: (1) Matching index (MI), which was the percentage of overlapped volume in 3-dimensions between 2 ITVs. When 2 ITVs were totally overlapped, MI was 1.00, whereas when 2 ITVs were totally separate, MI was 0; and (2) under- and over-estimated volume (V~under~and V~over~). A tested ITV (V ~test~) was compared to the standard volume, ITV~AllPhases~. The formulas were: V~under~*=*V~AllPhases~\\V~test~, and V~over~*=*V~test~\\ V~AllPhases~.

$$VUnder = \int Aallphase\left( Z \right)\backslash Atest\left( Z \right)dz$$

$$VOver = \int Atest\left( Z \right)\backslash Aallphase\left( Z \right)dz$$

The definitions and calculations of those metrics were referred to Ezhil \[[@B12]\].

Paired sample *t*-test and Independent-Samples T test (SPSS v.13, SPSS Inc., Chicago, IL) were applied to compare the differences with *p*value of \< 0.05 considered significant.

Results
=======

Patients
--------

From August 2010 to February 2011, 15 eligible patients with liver cancer were enrolled in this study and underwent 4D CT simulation for irradiation treatment planning in our institution. Of these patients 11 had metastatic liver cancers and 4, HCC with mean lesion volume of 152 cm^3^(range, 2 cm^3^- 932 cm^3^). 4D CT images were successfully obtained from 15 patients and tumor margins were clearly discernable in all patients. There were 9 cases of low density and 6, mixed on CT images (Table [1](#T1){ref-type="table"}).

###### 

Tumor Characteristics

  Patient   Tumor                              Tumor size\* (mm)   GTV(cm^3^)   Location                                        Tumor density
  --------- ---------------------------------- ------------------- ------------ ----------------------------------------------- ---------------
  1         HCC                                51 × 42 × 23        34           Right upper lobe; adjacent to right lung.       Mixed
  2         LM from lung cancer                33 × 49 × 33        30           Left lobe; intrahepatic                         Low
  3         LM from gastric carcinoma          42 × 78 × 52        77           Caudate and left lobe; intrahepatic             Low
  4         LM from pancreatic carcinoma       42 × 51 × 48        66           Right lower lobe; intrahepatic                  Mixed
  5         LM from nasopharyngeal carcinoma   12 × 15 × 15        2            Right upper lobe; intrahepatic                  Low
  6         LM from rectal carcinoma           10 × 12 × 11        2            Right upper lobe; intrahepatic                  Low
  7         HCC                                35 × 39 × 48        59           Right upper lobe; adjacent to right lung        Mixed
  8         LM from gallbladder carcinoma      9 × 18 × 18         3            Right lower lobe; intrahepatic                  Low
  9         LM from gastric carcinoma          51 × 99 × 58        213          Left lobe; adjacent to stomach                  Low
  10        HCC                                78 × 96 × 99        384          Right lobe; adjacent to right lung and kidney   Mixed
  11        LM from lung cancer                50 × 59 × 45        80           Left lobe; adjacent to stomach                  Low
  12        LM from gallbladder carcinoma      33 × 38 × 42        28           Right lobe; intrahepatic                        Low
  13        LM from rectal carcinoma           54 × 56 × 54        91           Right upper lobe; adjacent to right lung        Mixed
  14        HCC                                108 × 126 × 145     932          Right upper lobe; adjacent to right lung        Mixed
  15        LM from esophageal carcinoma       60 × 91 × 88        284          Right lobe; adjacent to right lung and kidney   Low

*Abbreviations:*GTV: gross tumor volume; HCC: hepatocellular carcinoma; LM: liver metastasis.

\*Tumor size was expressed as multiplying diameters in cranio-caudal, in left-right and in anterior-posterior directions.

Target motion
-------------

The cranio-caudal motion of the target was predominant with a mean distance of 8.0 mm ± 3.3 mm, while the left-right and anterior-posterior motions were much less with mean values of 1.6 mm ± 0.9 mm and 3.2 mm ± 2.2 mm, respectively (Table [2](#T2){ref-type="table"}).

###### 

Motion magnitudes of GTV centroid measured by 4D CT in 15 patients (mm)

  Patient   Cranio-caudal   Left-right   Anterior-posterior   3D vector
  --------- --------------- ------------ -------------------- -----------
  1         8.8             2.9          2.3                  9.6
  2         11.9            1.1          1.4                  12.0
  3         6.9             1.0          2.8                  7.5
  4         8.8             1.3          3.0                  9.4
  5         8.7             1.7          2.2                  9.1
  6         10.0            1.1          3.9                  10.8
  7         15.2            2.5          8.1                  17.4
  8         7.6             3.6          4.3                  9.5
  9         8.0             1.1          1.4                  8.2
  10        5.3             2.7          8.2                  10.1
  11        3.4             1.0          3.2                  4.8
  12        3.0             1.0          2.1                  3.8
  13        11.5            1.7          2.3                  11.9
  14        3.9             0.9          0.7                  4.1
  15        7.4             1.0          1.7                  7.7
  Mean      8.0             1.6          3.2                  9.1
  SD        3.3             0.9          2.2                  3.4

Comparison of ITVs countered by different approaches
----------------------------------------------------

### (1). ITVs volume

Table [3](#T3){ref-type="table"} shows all volumes of ITV. The mean volume of ITV~2M~was closest to that of ITV~AllPhases~, and then followed by ITV~2Phase~. The volume difference between ITV~2M~and ITV~2Phase~was statistically significant with a *p*value of 0.04. Taking ITV~AllPhases~as the reference, the mean ratios of the tested ITVs to ITV~AllPhases~were 88.9% ± 5.7%, 82.7% ± 12.6%, 82.5% ± 10.8% and 94.0% ± 3.6%, respectively for ITV~2phase~, ITV~MinIP~, ITV~MIP~and ITV~2M~.

###### 

Volumes of ITV~AllPhases~, ITV~2M~, ITV~2Phase~, ITV~MinIP~and ITV~MIP~(cm^3^)

  Patient   ITV~AllPhases~   ITV~2M~   ITV~2Phase~   ITV~MinIP~   ITV~MIP~
  --------- ---------------- --------- ------------- ------------ ----------
  1         52.8             44.2      43.2          32.5         41.5
  2         50.9             48.8      47.1          43.7         43.6
  3         112.6            101.4     102.4         97.5         80.9
  4         100.1            94.8      91.2          70.9         94.5
  5         5.7              5.1       4.3           5.0          4.1
  6         5.0              4.7       4.1           4.6          2.9
  7         96.1             91.4      85.3          56.0         90.0
  8         6.8              6.5       5.9           6.5          5.0
  9         294.8            283.0     280.6         233.3        275.2
  10        569.3            549.6     514.6         390.3        528.7
  11        99.5             95.7      88.9          93.8         86.2
  12        40.3             38.9      37.2          38.8         30.1
  13        123.2            116.8     110.0         98.9         104.9
  14        1082.7           1041.1    1040.3        963.8        1013.6
  15        372.0            357.6     347.3         355.7        312.5
  Mean      200.8            192.0     186.8         166.1        180.9
  SD        290.4            280.0     277.0         252.0        272.0

### (2). MI

As shown in Table [4](#T4){ref-type="table"}, ITV~2M~was closest matched with ITV~AllPhases~with mean MI of 0.93 ± 0.04, and mean MIs were 0.89 ± 0.06, 0.82 ± 0.12 and 0.82 ± 0.10, respectively for ITV~2Phase~, ITV~MinIP~and ITV~MIP~. The differences of MI were statistically significant between ITV~2M~and ITV~2Phase~(*p*= 0.004), between ITV~2M~and ITV~MinIP~(*p*= 0.003), and between ITV~2M~and ITV~MIP~(*p*= 0.000). All the other comparisons between ITVs were not significant.

###### 

MI values for four ITVs based on ITV~2M~, ITV~2Phase~, ITV~MinIP~and ITV~MIP~relative to the reference ITV~AllPhases~

  Patient   ITV~2M~   ITV~2Phase~   ITV~MinIP~   ITV~MIP~
  --------- --------- ------------- ------------ ----------
  1         .83       .82           .61          .78
  2         .94       .92           .86          .83
  3         .89       .91           .86          .72
  4         .93       .91           .71          .93
  5         .89       .75           .87          .73
  6         .91       .81           .91          .58
  7         .94       .89           .58          .93
  8         .95       .87           .95          .72
  9         .94       .95           .79          .92
  10        .95       .90           .68          .92
  11        .95       .89           .94          .86
  12        .95       .92           .95          .75
  13        .93       .89           .80          .84
  14        .96       .96           .89          .93
  15        .96       .94           .95          .84
  Mean      .93       .89           .82          .82
  SD        .04       .06           .12          .10

We further analyze the tumor characteristics, which would impact MI.

**1). MI and tumor volume:**As lesion of \> 5 cm is not a candidate for stereotactic body radiation therapy in our practice, the patients were split into two groups: ≤ 65.4 cm^3^(equivalent to the volume of a sphere with 5 cm in diameter) vs. \> 65.4 cm^3^. MIs of ITV~2M~were 0.94 ± 0.02 for the former and 0.92 ± 0.04 for the latter (*p*= 0.260). Nevertheless, there was significant difference between tumor size and MIs of ITV~2Phase~, MI being 0.92 ± 0.03 for tumor of ≤ 65.4 cm^3^and 0.85 ± 0.06 for tumor of \> 65.4 cm^3^(*p*= 0.015). For ITV~2M~as tumor volume increased MI did not change much with no correlation between them (R = 0.364, *p*= 0.182). However, for ITV~2Phase~, when tumor volume increased MI was significantly enhanced with positive correlation (R = 0.527, *p*= 0.044) (Figure [2](#F2){ref-type="fig"}).

![**Relationship between gross tumor volume and MI values of ITV~2M~and ITV~2Phase~**.](1748-717X-7-11-2){#F2}

**2). MI and target motion three-dimensionally:**It is recommended that for tumor motion of \> 10 mm, we need to reduce the movement by breath control devices, such as Active Breathing Coordinator or RPM gating system. The patients were divided into two groups: 3D vector of ≤ 10 mm vs. \> 10 mm. Mean MIs of ITV~2M~were 0.94 ± 0.01 and 0.92 ± 0.04 (*p*= 0.542), and mean of MIs of ITV~2Phase~, 0.88 ± 0.04 and 0.89 ± 0.06 (*p*= 0.756), respectively for the former and the latter. There was no significant correlation between the magnitude of target motion and MI.

**3). MI and ratio of tumor vertical diameter over tumor motion magnitude in cranio-caudal direction:**As shown in Figure [3](#F3){ref-type="fig"}, for ITV~2M~when vertical diameter over tumor motion magnitude in cranio-caudal direction increased MI was increased slightly, but with no significant correlation (R = 0.352, *p*= 0.198). However, for ITV~2Phase~there was a positive correlation between them (R = 0.535, *p*= 0.040).

![**The relationship between the ratio of tumor vertical diameter over tumor motion magnitude in cranio-caudal direction and MI values of ITV~2M~and ITV~2Phase~**.](1748-717X-7-11-3){#F3}

**4). MI and tumor density:**For the tumor of low density or mixed density, there was no significant difference in MIs between them for both ITV~2M~and ITV~2Phase~, MIs of ITV~2M~being 0.93 ± 0.02 and 0.92 ± 0.05 (*p*= 0.676), and MIs of ITV~2Phase~, 0.88 ± 0.07 and 0.90 ± 0.05 (*p*= 0.702), respectively for low density tumor and the mixed. However, for low density tumor MI of ITV~MinIP~was better than that for mixed density tumor with MI of 0.90 ± 0.05 and 0.71 ± 0.11 (*p*= 0.001), respectively.

We also noticed that for low density tumors, which located within liver parenchyma and were not closed to adjacent organs, such as 5^th^, 6^th^, 8^th^and 12^th^patient (Table [1](#T1){ref-type="table"}), when using ITV~MinIP~mean MI was 0.92 ± 0.04, while using ITV~2M~it was 0.93 ± 0.03 with no significant difference between ITV~MinIP~and ITV~2M~(*p*= 0.114).

### (3). Proportion of V~under~

Figure [4](#F4){ref-type="fig"} illustrates the proportions of V~under~in 15 patients. Compared to ITV~AllPhases~, the proportional V~under~of ITV~2M~was the lowest (0.07 ± 0.04) with the maximum of 0.17 among ITV~2Phase~, ITV~MinIP~, ITV~MIP~and ITV~2M~. While proportional V~under~of ITV~2Phase~was 0.11 ± 0.06 with the maximum of 0.26. The mean proportion of V~under~for ITV~2M~were significantly less than that for ITV~2Phase~(*p*= 0.001). However, ITV~MinIP~and ITV~MIP~underestimated larger volumes, the proportions of V~under~being 0.18 ± 0.12 and 0.18 ± 0.11, respectively.

![**The proportional volumetric underestimations of each ITV (ITV~2M~, ITV~2Phase~, ITV~MinIP~and ITV~MIP~) relative to the reference ITV~AllPhases~in the 15 individual patients**.](1748-717X-7-11-4){#F4}

The analyses of tumor characteristics, which would impact proportion of V~under~were as follows.

**1). Proportion of V~under~and tumor volume:**There were no correlations between the diameter of GTV and the proportion of V~under~for ITV~2M~, no matter the diameter over than or less than 5 cm. The proportions of V~under~were respectively 0.06 ± 0.02 and 0.08 ± 0.05 (*p*= 0.244). However, there was significant difference in proportion of V~under~between tumor size of ≤ 5 cm and \> 5 cm with proportions of ITV~2Phase~being 0.08 ± 0.03 and 0.15 ± 0.07 (*p*= 0.018), respectively. For ITV~2M~as tumor size increased the proportions of V~under~did not change significantly with no correlations between them (R = -0. 340, *p*= 0.215). In contrast, for ITV~2Phase~there was negative correlation between GTV volume and the proportion of V~under~(R = -0.528, *p*= 0.043) (Figure [5](#F5){ref-type="fig"}).

![**Relationship between gross tumor volume and proportional volumetric underestimations of ITV~2M~and ITV~2Phase~**.](1748-717X-7-11-5){#F5}

**2). Proportion of V~under~and target motion three-dimensionally:**There was no strong correlation between 3 victor tumor motion of ≤ 10 mm and \> 10 mm, and the proportions of V~under~were 0.06 ± 0.01 and 0.07 ± 0.04 (*p*= 0.480) for ITV~2M~, and 0.12 ± 0.04 and 0.10 ± 0.07 (*p*= 0.758) for ITV~2phase~.

**3). Proportion of V~under~and ratio of tumor vertical diameter over tumor motion:**For ITV~2M~there was no strong correlation between them (R = -0.344, *p*= 0.210). However, for ITV~2phase~as ratio of tumor vertical diameter over tumor motion increased the proportions of V~under~decreased significantly (R = -0.523, *p*= 0.040) (Figure [6](#F6){ref-type="fig"}).

![**The relationship between the ratio of tumor vertical diameter over tumor motion magnitude in cranio-caudal direction and proportional volumetric underestimations of ITV~2M~and ITV~2Phase~**.](1748-717X-7-11-6){#F6}

**4). Proportion of V~under~and tumor density:**For both low density and mixed density tumors there was no significant difference in the underestimations, regardless ITV~2M~or ITV~2Phase~, For ITV~2M~the proportions of V~under~were 0.06 ± 0.03 and 0.07 ± 0.05 (*p*= 0.723), respectively for low density tumor and the mixed, and for ITV~2Phase~they were 0.12 ± 0.07 and 0.11 ± 0.05 (*p*= 0.680). However, when using ITV~MinIP~the underestimated proportion was 0.10 ± 0.06 for 9 low density tumors, but it was 0.29 ± 0.11 for 6 mixed density tumors (*p*= 0.001).

As for MI in 5^th^, 6^th^, 8^th^and 12^th^patient, when ITV~MinIP~was used the mean proportion of V~under~was 0.08 ± 0.04, while it was 0.07 ± 0.03 when ITV~2M~was used (*p*= 0.094).

### (4). V~over~

Compared to ITV~AllPhases~, the percentages of V~over~were all less than 1% for ITV~2phase~, ITV~MinIP~, ITV~MIP~and ITV~2M~.

Discussion
==========

MIP method as an image post-processing is based on more complex algorithms and can be used for generating three-dimensional vascular reconstructions \[[@B14],[@B15]\]. In lung cancer, MIPs are believed to be a reliable tool to generate ITVs from 4D CT data sets \[[@B10]\], however, it is mandatory to modify each individual MIP to improve ITV delineation for tumors adjacent to the thoracic wall, mediastinum, heart, or diaphragm \[[@B11],[@B12]\]. In the current study, we also had to verify ITVs contoured on MIP and MinIP CT by overlaying it on a movie loop displaying 4D CT data and then editing it, especially for those closed to adjacent organs. Mancosu had recently proposed a semiautomatic technique, which allowed for inclusion of the residual part of ITV covered by liver and spleen cupola when using MIP algorithm. It was validated on phantom and selected patients, which revealed this possibility when lesion located near liver and spleen cupola by performing only the contours on MIP series \[[@B16]\]. Thus, the dedicated software needs to be developed to exclude diaphragm and chest wall in some breathing phases using 4D CT for better tumor MIP/MinIP images.

Theoretically, for tumors with homogeneous hyperdensity or hypodensity compared to the surrounding normal liver, MIP or MinIP projections should accordingly reflect the tumor trajectory across all time-resolved data sets. In patients when the lesions were homogenous low CT density, located intrahepatic, not adjacent to perihepatic organs and also small size (5^th^, 6^th^, 8^th^and 12^th^patient), using MinIP was also an appropriate tool with good MI of 0.92 ± 0.04 and low proportion of V~under~of 0.08 ± 0.04. Thus, ITV~MinIP~method can be used for fast contouring of liver tumor with homogeneous low CT density including respiratory motion.

However, a number of liver cancers present inhomogeneous density, results from this study showed combined MIP and MinIP fit excellently in this situation. In current study we compared MIs and proportions of V~under~resulting from ITV~2Phase~, ITV~MinIP~, ITV~MIP~and ITV~2M~contoured by 4 approaches, and found that the closest to ITV~AllPhases~was the combined one (ITV~2M~) of ITV~MinIP~and ITV~MIP~, which were contoured on MinIP and MIP series of 4D CT set because it resulted in the highest MI and lowest proportion of V~under~. Moreover, the size of tumor and the ratio of tumor vertical diameter over cranio-caudal movement did not have influence on MI or proportion of V~under~when using ITV~2M~. In other words, no matter how big the tumor was, and the tumor vertical diameter over cranio-caudal movement was small or big, the tool of ITV~2M~could always result in the best outcome.

For moving target it was also a practice to sum 2 GTVs to generate ITV, one contoured on CT image set acquired after end-inhale and holding breath and the other contoured on CT acquired after end-exhale and holding breath when 4D CT was not available. The similar method was also used for 4D CT, i.e., to contour only two extreme phases at end-inhalation and end-exhalation. However, possible hysteresis effects would be neglected as occurred in lung cancer \[[@B17],[@B18]\]. Seppenwoolde and colleagues \[[@B18]\] reported that when the tumor was small and had a large range of motion, the separation between the positions of the images of inspiration and expiration phases was relatively obvious and the information of the intermediate breathing might not be comprehensive. Besides, the combined images of the two time phases might omit the lag of the tumor. The phenomenon was caused by the time difference among the document recorded by the computer, the transition of respiratory cycle and the transition between inspiration and expiration in a respiratory cycle. Xi \[[@B9]\] reported the feasibility of using limited 4D CT images for treatment planning for liver radiotherapy. As recognized by the authors, deriving ITV by two extreme phases was reasonably safe only for low and medium tumor motion amplitude (\< 1.6 cm). The tumor motion in cranio-caudal direction between Xi\'s study and ours\' were comparable, but the tumor size of our data (152.20 cm^3^± 242.85 cm^3^) was more diverse than Xi\'s (70.36 cm^3^± 66.23 cm^3^). Xi did not investigate the influence of tumor size on ITV determination using 4D CT data. Our study did find a smaller volume of ITV~2Phase~(186.8 cm^3^) than that of ITV~AllPhases~(200.8 cm^3^) with significant difference (*p*= 0.004). And also we found that MI and proportion of V~under~were influenced by the tumor volume and the ratio of tumor size over tumor motion magnitude significantly. Whereas, ITV~2M~was the closest to ITV~AllPhases~, and MI and proportion of V~under~were not influenced by tumor volume and the ratio of tumor size over tumor motion magnitude when using tool of ITV~2M~.

Conclusion
==========

To reduce the workload of contouring multiple GTVs in 4D CT data sets, contouring only two extreme phases is appropriate only when tumor volume is big and tumor motion magnitude is relatively small. For hepatic malignancies with inhomogeneous density we found that the method of using ITV~2M~was a more reliable and appropriate tool for generating ITVs from 4D CT data sets, compared to the others.
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